Huang and colleagues have shown that the lncRNA EPB41L4A-AS2 was downregulated in docetaxel-resistant MDA-MB-231 and MCF-7 breast cancer cells, and lower EPB41LA4-AS2 expression was associated with the upregulation of ABCB1 and the promotion of docetaxel resistance in breast cancer cells [162]. Here, ABCB1 is linked to breast carcinoma.